Organ donors are sources of physiologically healthy organs and tissues for life-saving transplantation, and have been recently used for human immunology studies which are typically confined to the sampling of peripheral blood. Donors comprise a diverse population with different causes of death and clinical outcomes during hospitalization, and the effects of such variations on immune parameters in blood and tissues are not known. We present here a coordinate analysis of innate and adaptive immune components in blood, lymphoid (bone marrow, spleen, lymph nodes), and mucosal (lungs, intestines) sites from a population of brain-dead organ donors (2 months-93 years; n = 291) across eight clinical parameters. Overall, the blood of donors exhibited similar monocyte and lymphocyte content and low serum levels of pro-inflammatory cytokines as healthy controls; however, donor blood had increased neutrophils and serum levels of IL-8, IL-6, and MCP-1 which varied with cause of death. In tissues, the frequency and composition of monocytes, neutrophils, B lymphocytes and T cell subsets in lymphoid or mucosal sites did not vary with clinical state, and was similar in donors independent of the extent of clinical complications. Our results reveal that organ donors maintain tissue homeostasis, and are a valuable resource for fundamental studies in human immunology. 
predominant innate immune cells, and T and B lymphocytes as the cellular components of adaptive immunity. However, the majority of innate and adaptive immune cells reside in tissues, including subsets of immune cells that do not enter circulation (eg, dendritic cells, macrophages, and tissueresident memory T cells). Moreover, the anatomical localization and tissue compartmentalization of immune cells is emerging as a key factor in their function, regulation, and maintenance. [6] [7] [8] Because of the logistical and ethical difficulties involved in acquiring human tissues, immunology studies have used surgical explants or biopsies of single sites derived from diseased tissues of small cohorts. [9] [10] [11] [12] [13] [14] [15] [16] Results from such studies, while providing views into tissue immune cell populations, cannot be extrapolated to understanding baseline immune health in the diverse population.
Compared to the multiple caveats involved in use of tissue biopsies and explants, tissues from recently deceased organ donors provide multiple advantages for the study of human immunity including:
( T A B L E 1 (Continued) F I G U R E 1 Characteristics of deceased organ donors analyzed in this study. Tissues from research-consented organ donors were obtained for analysis of immune cells from 291 donors between February 2011 and October 2016. A, graph shows number of donors of each age spanning 2 months to 93 years of age (n = 291), stratified into the following age categories: Pediatric, 0-15 years of age; Young adult, 16-35 years of age; Middle years, 36-65 years of age; Senior, >65 years of age. B, Graph shows stratification of gender (left) and cause of death (right) by age range. C, bar graphs showing eight clinical characteristics stratified by donor age category. Clinical characteristics include: noncerebrovascular accident (CVA) as cause of death (COD); need for cardiopulmonary resuscitation (CPR); brain death duration greater than 48 h (BDD >48 h); length of stay (LOS) greater than 1 week; administration of steroids (1 g Solumedrol every 24 h) after the diagnosis of brain death; presence of acute lung injury (ALI) as diagnosed by Berlin criteria (see Supplemental methods); whether or not the donor received a packed red blood cell or platelet transfusion during their hospitalization ("Transfusion"); and, whether or not the donor had a positive blood or urine culture at any point during their hospitalization (Culture positive) subset distribution and heterogeneity throughout the body and across the lifespan in tissues from over 100 individuals, 19, 21, 23 
| MATERIALS AND METHODS

| Experimental design
Blood, mucosal, and lymphoid tissues were obtained from research- 
| Isolation of cells from tissue sites
Tissue collection occurred after the donor organs were flushed with cold preservation solution and clinical procurement was completed.
Tissues were processed within 2-4 hours of organ procurement resulting in high yields of live immune cells 17, 19, 23 (see online methods). For blood samples, lymphocytes were isolated by centrifugation through lymphocyte separation medium (Corning, Manassas, VA); monocytes and neutrophils were isolated using whole blood lysis techniques with ACK lysing buffer (Lonza, Walkersville, MD).
| Immune cell analysis by flow cytometry
Single-cell suspensions were stained with fluorochrome-conjugated antibodies (Table S2) 
| Quantitation of serum cytokines
Blood was stored in EDTA-coated collection tubes and then centrifuged to isolate the serum fraction. Serum cytokine content was quantitated using cytometric bead arrays (LEGENDplex Human Inflammation 13-plex Panel; Biolegend, San Diego, CA), and assessed by flow cytometry compared to control standards as indicated by the manufacturer.
| Clinical data
All clinical data were obtained from DonorNet, the Organ Procurement immunological analysis was compiled from donors ≥16 years. 
| Statistical analysis
Comparison of serum cytokine levels in organ donors and healthy controls. A, Levels of multiple cytokines in the serum of organ donors (n = 47) and healthy controls (n = 13) expressed as pg/mL (mean ± SEM). N.S. = not significant. Significant differences between levels in donors and healthy controls were identified for MCP-1 (P < .001), IL-6 (P = .0041), and IL-8 (P = .0129) (*P < .05, **P < .01). B, Matrix shows serum cytokine concentrations as a function of eight measured clinical characteristics as defined in Figure 1C (COD, cause of death; CPR, cardiopulmonary resuscitation; LOS, length of stay >1 week with the mean LOS being 5.5 days; BDD, brain death duration greater than 48 h which was the mean length of brain death; Transfusion, whether or not a donor received any packed red blood cell or platelet transfusion; Cx Data, whether or not donors had a positive blood or urine culture during their hospitalization.) The matrix grid shows an ANOVA analysis analyzing the presence/absence of each factor in each tissue. Shaded pink boxes indicating significant (P < .05) positive correlation with the factor and shaded blue boxes indicating negative correlation with the factor with "T" denoting had trauma for COD. For MCP-1, the significance for each factor was: P = .0280 for higher levels of MCP-1 in HT vs stroke; P = .006 for higher MCP-1 in donors with BDD >48 h; P = .0034 for higher MCP-1 in donors with LOS >1 week; P < .001 for higher MCP-1 levels in donors who had transfusions; and P < .001 for higher MCP-1 levels in culture+ donors. IL-6 was higher in donors with infections (P = .06) 
| RESULTS
| Study population and donor characteristics
Between February 2011 and October 2016, we obtained tissues from 291 research-consented organ donors (Table 1) . Donors were aged 2 months to 93 years of age (mean = 39.7 years, 66% male, Figure 1A ).
All donors met brain death criteria: 22% from head trauma (HT), 38%
from anoxia, and 40% from stroke. COD varied significantly by age; younger donors were more likely to die from HT (P < .001) while more older donors died of stroke (P < .001) ( Table 1 and Figure 1B) . CPR was required prior to organ procurement in 47% of donors, with the highest rate of CPR (88%) in donors who died of anoxic compared to other causes (P < .001, Table 1 ). In terms of medical comorbidities, 14% of donors had Type II diabetes mellitus (DM), 31% were obese, 37% had hypertension, 6% had coronary artery disease, 6% were intravenous drug abusers, and 18% were smokers ( Figure 1B Table 1 ).
COD varied significantly, in which median age was highest for donors who died of stroke and lowest for donors who died of HT (P < .001).
Pediatric and young adult donors were most likely to receive CPR and transfusions prior to organ donation, and to have shorter lengths of stay and brain death durations. Young adult donors were more likely to sustain ALI prior to organ donation. Finally, young adults and middleaged donors had the highest rates of infections, also associated with anoxia (Table 1) . Thus, the conditions and circumstances of death and subsequent hospitalization varied significantly by age.
| Variation in blood immune cells and cytokines among donors
We initially examined the frequency of innate (myeloid lineage) and 
| Myeloid and lymphoid lineage analysis and variation by clinical parameter
We performed a systematic analysis of myeloid (monocyte, neutrophil) and lymphocyte (T, B) lineage cells in lymphoid and mucosal tissues Figure 1C . The matrix grid shows an ANOVA analysis with shaded pink boxes indicating significant (P < .05) positive correlation with the factor and shaded blue boxes indicating negative correlation with the factor. Significance level for each factor was as follows: for monocytes, a higher frequency in the blood (P = .0043) and lung (P < .001) was associated with anoxia (labeled "A") compared to donors who died of stroke, while higher monocyte frequency in blood was also associated with CPR (P = .0293). For neutrophils, donors who died of stroke (labeled "S") had significantly higher frequencies in the blood (P = .0417) and spleen (P = in blood and 9 tissue sites (n = 82). D, Matrix of significant association (P < .05) of T cell subset frequencies with eight clinical parameters without adjustments for age (top), and adjusted for age as a covariate (bottom), as defined in Figure 1C . The matrix grid shows an ANOVA analysis analyzing the presence/absence of each factor in each tissue. Shaded pink boxes indicating significant (P < .05) positive correlation with the factor and shaded blue boxes indicating negative correlation with the factor. In the age-adjusted analysis, HT ("T") as a COD was associated with significantly higher CD4 + naïve cells (P < .001) and CD8 + naïve cells (P = .002) in the LLN compared to donors who died of a stroke ("S") studies have yielded consistent results on tissue-specific immune cell populations between disparate individuals 17, 19, 21, 23, 24 ; however, do- living donors have identified differences in immune parameters, [40] [41] [42] [43] [44] although the timing of biopsies and cold ischemia time may impact those results. 40 All of our donors met brain death criteria, not allowing us to discern living versus deceased changes.
| T cell subset distribution is stably maintained
Our understanding of human immunology is largely dependent on knowledge obtained from sampling of blood and extrapolated from T A B L E 4 Correlation between serum cytokine levels and immune cell frequencies in peripheral blood of organ donors Correlation data between serum cytokine concentrations and peripheral blood immune cell frequencies (n = 47). Light gray (P < .10); dark gray (P < .05).
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